InvestorsHub Logo
Followers 189
Posts 29434
Boards Moderated 1
Alias Born 08/29/2012

Re: sharkey1 post# 621

Friday, 08/05/2022 6:27:50 AM

Friday, August 05, 2022 6:27:50 AM

Post# of 690
Products & Pipeline


Drug Market Size Approved Launched Competitors Marketing Partner Notes
Adderall 338 M Yes Yes 11 Lannett 50% owned by Mikah Pharma
Adderall XR 1.5 B Yes Yes 8 Lannett 50% owned by Mikah Pharma
Dantrolene 6.3 M Yes Yes 2 Lannett
Isradipine 5.5 M Yes Yes 1 Epic
Loxapine 5 M Yes Yes 3 Prasco On FDA drug shortage list
Naltrexone 16 M Yes Yes 5 Tagi
Phendimetrazine 4.5 M Yes Yes 4 Elite distributes on their own
Phentermine Capsules 7.5 M Yes Yes 7 Tagi
Phentermine Tablets 40 M Yes Yes 9 Tagi
Trimipramine 2 M Yes Yes 1 Epic
Tylenol with Codeine 45 M Yes No 4 On hold. See latest 10-K.
SunGen Antibiotic #1 85 M No No Unknown Filed. Awaiting FDA approval.
SunGen Antibiotic #2 70 M No No Unknown In negotiations with SunGen
SequestOx Unknown No No Unknown On hold. See latest 10-K.
Undisclosed ANDA #1 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #2 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #3 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #4 Unknown No No Unknown To be filed CY 2022
Undisclosed ANDA #5 Unknown No No Unknown To be filed CY 2023
Undisclosed ANDA #6 Unknown No No Unknown To be filed CY 2023
Undisclosed ANDA #7 Unknown No No Unknown To be filed CY 2023
Undisclosed ANDA #8 Unknown No No Unknown To be filed CY 2023
[/img]
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.